A detailed history of Two Sigma Investments, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Two Sigma Investments, LP holds 199,736 shares of LLY stock, worth $159 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
199,736
Previous 225,780 11.54%
Holding current value
$159 Million
Previous $204 Million 13.43%
% of portfolio
0.42%
Previous 0.5%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $20.1 Million - $25 Million
-26,044 Reduced 11.54%
199,736 $177 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $112 Million - $140 Million
154,159 Added 215.24%
225,780 $204 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $16.3 Million - $21.8 Million
-27,575 Reduced 27.8%
71,621 $55.7 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $175 Million - $207 Million
-333,538 Reduced 77.08%
99,196 $57.8 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $188 Million - $259 Million
432,734 New
432,734 $232 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $94.6 Million - $110 Million
294,302 New
294,302 $108 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $123 Million - $144 Million
-440,736 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $8.05 Million - $10 Million
34,317 Added 8.44%
440,736 $126 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $133 Million - $165 Million
-590,491 Reduced 59.23%
406,419 $112 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $192 Million - $236 Million
866,697 Added 665.6%
996,910 $230 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $18.2 Million - $21 Million
124,275 Added 2092.88%
130,213 $19.3 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $67 Million - $80.7 Million
-491,246 Reduced 98.81%
5,938 $975,000
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $4.66 Million - $5.77 Million
39,140 Added 8.55%
497,184 $69 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $30.7 Million - $38 Million
286,918 Added 167.66%
458,044 $60.2 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $10.8 Million - $11.8 Million
-101,211 Reduced 37.16%
171,126 $19.1 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $27.2 Million - $31.7 Million
245,390 Added 910.64%
272,337 $30.2 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $124 Million - $139 Million
-1,175,303 Reduced 97.76%
26,947 $3.12 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $52.5 Million - $65.6 Million
611,453 Added 103.5%
1,202,250 $129 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $94.7 Million - $109 Million
-1,250,911 Reduced 67.92%
590,797 $50.4 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $124 Million - $146 Million
1,668,278 Added 961.93%
1,841,708 $142 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $14.2 Million - $15.2 Million
173,430
173,430 $14.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.